Overview
Employees
51-200
Total raised
$6.3M
Founded date
2011
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 5, 2014 | Neurovance Raises $6.3M Extension in Series A1 Round | Neurovance, a Cambridge, Mass.-based clinical stage neuroscience company focused on treating adult attention deficit hyperactivity disorder, raised a $6.3m extension in its Series A1 round. Backers included Novartis Venture Fund, Venture In... |
| Apr 3, 2014 | Neurovance Closes $6.3M Financing | CAMBRIDGE, MA, Neurovance, Inc. today announced that it has closed a $6.3 million extension to its series A1 financing round. >> Click here for more funding data on Neurovance >> To export Neurovance funding data to PDF and ... |
| Oct 19, 2012 | Neurovance Closes $7M Series A1 Funding | Neurovance, Inc., a Cambridge, Massachusetts-based a spinout of Euthymics Bioscience, Inc., has closed a $7m Series A1 round. The investment was led by existing investor Novartis Venture Fund, with participation from existing investors Vent... |
| Oct 18, 2012 | Novartis leads $7M round for ADHD drug upstart Neurovance | Novartis Venture Fund has stepped up to spearhead a $7 million A1 round for the Cambridge, MA-based startup Neurovance. The fledgling biotech was spun out of Euthymics Bioscience under the same management group to handle the development of ... |
| Oct 18, 2012 | Neurovance Closes $7M Series A1 Round | CAMBRIDGE, MA, Neurovance, Inc. today announced that it has closed a $7 million series A1 round led by existing investor Novartis Venture Fund. >> Click here for more funding data on Neurovance >> To export Neurovance fundin... |
Reviews 0
FAQ about Neurovance
When was Neurovance founded?
Neurovance was founded in 2011.
How much funding has Neurovance raised?
Neurovance has raised $6.3M in total across 1 funding round.
What has the press written about Neurovance?
Parsers VC has collected 6 articles mentioning Neurovance, among them “Neurovance Raises $6.3M Extension in Series A1 Round” (Apr 5, 2014) and “Neurovance Closes $6.3M Financing” (Apr 3, 2014).
Is Neurovance still active?
Yes, Neurovance is active; its latest activity on Parsers VC dates from Mar 3, 2017.